Combination of immunotherapy and fruquintinib in metastatic colorectal cancer: the key to overcome resistance?

Immunotherapy. 2024;16(20-22):1171-1173. doi: 10.1080/1750743X.2024.2430173. Epub 2024 Nov 16.

Authors

Tarek Assi¹, Mohamad Ali Hachem¹, Roula Amine-Hneineh¹, Tania Moussa²

Affiliations

¹ Division of International Patients Care, Gustave Roussy Cancer Campus, Villejuif, France.
² Radiology Department, Gustave Roussy Cancer Campus, Villejuif, France.

PMID: 39548753
PMCID: PMC11760286 (available on 2025-11-16)
DOI: 10.1080/1750743X.2024.2430173

No abstract available

Keywords: Colorectal; cancer immunology; checkpoint inhibitors; colon; fruquintinib; immunotherapy; tyrosine kinase inhibitors.

Publication types

Editorial

Grants and funding

This paper was not funded.